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Introduction {#sec001}
============

Tuberculosis (TB) remains a serious global public health problem in the present. According to the report of World Health Organization (WHO), the estimated global incidence of TB cases in 2018 was 10.0 million \[[@pone.0237753.ref001]\]. TB is a multi-systemic disease with a protean presentation. Pulmonary tuberculosis (PTB) is the most common clinical presentation of TB. TB also affects other sits (extrapulmonary tuberculosis, EPTB), such as pleura, lymph nodes, skeleton, meninges, etc \[[@pone.0237753.ref002],[@pone.0237753.ref003]\]. In contrast to PTB, the research of EPTB is less concerned by public health institutions. This may be because most forms of EPTB do not contribute to the spread of tuberculosis \[[@pone.0237753.ref004],[@pone.0237753.ref005]\], or sometimes patients with PTB and EPTB at the same time are classified as PTB cases \[[@pone.0237753.ref003]\]. In fact, EPTB accounts for a significant proportion of tuberculosis cases worldwide. Many studies have found a high proportion (20%-53%) of cases presenting with EPTB in all the cases of TB \[[@pone.0237753.ref005]--[@pone.0237753.ref008]\]. In clinical practice, concurrent other type of TB in EPTB patient is common \[[@pone.0237753.ref009],[@pone.0237753.ref010]\]. Due to the atypical clinical symptoms, no characteristic imaging manifestation, difficulty in obtaining specimens, and low positive rate of etiology in EPTB, the diagnosis of EPTB is very difficult and easy to be misdiagnosed. Meanwhile, the presence of concurrent other types of TB in EPTB often complicates the diagnosis and clinical treatment, and may contribute to poor or unsatisfactory clinical outcomes in these patients. In order to comprehensively understand epidemiology of EBTB in China, and improve early diagnosis and treatment, we conducted a large-scale multi-center observational study to assess the demographic data and the prevalence of common EPTB inpatients, and further evaluate the prevalence of EPTB concurrent with PTB and the associations between multiple EPTB types and gender-age group in China.

Methods {#sec002}
=======

In this study, EPTB patients were defined as those who have at least one EPTB disease site, including EPTB concurrent with PTB patients. According to WHO, EPTB cases were mainly categorized by the disease site \[[@pone.0237753.ref011]\]. The study was performed utilizing data of 21 hospitals from 15 provinces in China, most of which are specialized tuberculosis hospitals. All consecutive age≥15yr inpatients with a confirmed diagnosis of EPTB during the period from January 2011 to December 2017 were included in the study. Diagnosis of TB in these patients were undertaken utilizing WHO guidelines \[[@pone.0237753.ref012]\] and the clinical diagnosis standard for TB issued by the Chinese Medical Association \[[@pone.0237753.ref013]\]. In China, the diagnosis of tuberculosis generally adopts traditional and modern methods, relying on clinical symptoms and signs, together with the results of bacteriology tests, the tuberculin skin test (TST), X-ray /CT examination, pathological examination, T-SPOT.TB, Gene Xpert MTB/RIF assay, and the successful outcome of treatment with a course of anti-tuberculosis chemotherapy, etc. We referred to the patients' medical history record to collect medical and demographic information. Data collection and manuscript preparation were completed in accordance with the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) statement \[[@pone.0237753.ref014]\].

Statistical analysis {#sec003}
--------------------

Descriptive statistical analysis includes median and quartile measurements of continuous variables, and 95% confidence interval (CIS) frequency and proportion of categorical variables. Multinomial logistic regression analysis was used to compare the association of multiple EPTB types between age group and gender. Primary analyses were based on tests for trends, modeling the ordered age categories as linear terms. A *p*-value \<0.05 was considered to be statistically significant. Odds ratios (ORs) with 95% confidence intervals (CIs) for age group and gender were calculated. All analyses were performed on the entire study population, as well as on six groups stratified by age (15--24 years, 25--34 years, 35--44years, 45--54years, 55--64years and≥65 years) and by gender. All data are sorted out in Microsoft Office Excel (Microsoft, Redmond, WA, USA) data table, and all analysis is conducted with SPSS software, version 13 (Chicago, USA).

Ethics statement {#sec004}
----------------

This was a multi-center observational retrospective study. Given that the medical information of inpatients was recorded necessarily and anonymously by case history, and that our data analysis could not necessarily cause any breach of the privacy of, or present any undue personal risk to the participants in this study, the Ethics Committee of Beijing Chest Hospital, Capital Medical University, approved this study, with a waiver of informed consent from the patients involved.

Results {#sec005}
=======

Patient characteristics {#sec006}
-----------------------

A total of 202,998 EPTB inpatients (age≥15 yr) from January 2011 to December 2017 were recruited at 21 hospitals from 15 provinces in China. And there were 416910 total TB patients. Demographic data for our patient cohort was shown in [Table 1](#pone.0237753.t001){ref-type="table"}. The ratio of male: female was 1.51. The proportion of 15--24 years and 25--34 years in EPTB inpatients were the most. Approximately 70% of EPTB inpatients were concurrent with PTB or other types of EPTB. The most common types of EPTB were EPTB concurrent with PTB (62.56%), followed by exclusively EPTB (32.64%), and EPTB concurrent with other types of EPTB (without PTB) (4.80%).

10.1371/journal.pone.0237753.t001

###### The demographic data of EPTB inpatients.

![](pone.0237753.t001){#pone.0237753.t001g}

  Variables                                                 N = 202998   Proportion (%)
  --------------------------------------------------------- ------------ ----------------
  **Gender**                                                             
   Female                                                   80860        39.83
   Male                                                     122138       60.17
  **Age group**                                                          
   15-24years                                               42916        21.14
   25-34years                                               42569        20.97
   35-44years                                               28519        14.05
   45-54years                                               29671        14.62
   55-64years                                               26946        13.27
   ≥65years                                                 32377        15.95
  **EPTB types**                                                         
   exclusively EPTB                                         66249        32.64
   EPTB concurrent with PTB                                 127005       62.56
   EPTB concurrent with other types of EPTB (without PTB)   9744         4.80

The prevalence of most common of EPTB (0.4% or about ≥800 cases) {#sec007}
----------------------------------------------------------------

Our data analysis revealed that there were 364,694 TB lesions in 202,998 EPTB inpatients. On average each EPTB inpatient had 1.80 types of TB lesions. The most common of EPTB (0.4% or about ≥800cases) was tuberculous pleurisy (50.15%, 95%CI:49.93%-50.37%), followed by bronchial tuberculosis (14.96%, 95%CI: 14.80% -15.12%), tuberculous lymphadenitis of the neck (7.24%, 95%CI:7.13%-7.36%), tuberculous meningitis (7.23%, 95%CI:7.12%-7.35%), etc ([Table 2](#pone.0237753.t002){ref-type="table"}).

10.1371/journal.pone.0237753.t002

###### The prevalence of most common of EPTB types (0.4% or ≥800 cases).

![](pone.0237753.t002){#pone.0237753.t002g}

  EPTB diagnosis                            N        Proportion(95%CI) (%)
  ----------------------------------------- -------- -----------------------
  tuberculous pleurisy                      101808   50.15(49.93--50.37)
  bronchial tuberculosis                    30367    14.96(14.80--15.12)
  tuberculous lymphadenitis of the neck     14706    7.24(7.13--7.36)
  tuberculous meningitis                    14680    7.23(7.12--7.35)
  tuberculous peritonitis                   9731     4.79(4.70--4.89)
  tuberculous empyema                       7203     3.55(3.47--3.63)
  lumbar vertebra tuberculosis              7019     3.46(3.38--3.54)
  tuberculous pericarditis                  5766     2.84(2.77--2.91)
  thoracic vertebra tuberculosis            5196     2.56(2.49--2.63)
  tuberculous polyserositis                 4734     2.33(2.27--2.40)
  intestinal tuberculosis                   4571     2.25(2.19--2.32)
  chest wall tuberculosis                   4539     2.24(2.17--2.30)
  tuberculosis of mediastinal lymph nodes   3292     1.62(1.57--1.68)
  renal tuberculosis                        2772     1.37(1.32--1.42)
  pharyngeal and laryngeal tuberculosis     2360     1.16(1.12--1.21)
  pelvic tuberculosis                       1816     0.89(0.85--0.94)
  tuberculosis of axillary lymph nodes      1260     0.62(0.59--0.66)
  knee joint tuberculosis                   1121     0.55(0.52--0.59)
  tuberculosis of hilar lymph nodes         1001     0.49(0.46--0.52)
  pleural tuberculoma                       888      0.44(0.41--0.47)
  hip joint tuberculosis                    878      0.43(0.40--0.46)
  cutaneous tuberculosis                    849      0.42(0.39--0.45)

Prevalence = N\*100%/202998.

The prevalence of EPTB concurrent with PTB {#sec008}
------------------------------------------

It was found that many EPTB inpatients concurrent with PTB. The highest prevalence of EPTB concurrent with PTB was pharyngeal/laryngeal tuberculosis (91.31%), followed by bronchial tuberculosis (89.52%), tuberculosis of hilar lymph nodes (79.52%), tuberculosis of mediastinal lymph nodes (79.13%), intestinal tuberculosis (72.04%), tuberculous pleurisy (65.31%) and tuberculous meningitis (62.64%), etc. The EPTB(≥800 cases) concurrent with PTB (proportion≥30%) were shown in [Table 3](#pone.0237753.t003){ref-type="table"}, sorted by proportion.

10.1371/journal.pone.0237753.t003

###### The prevalence of EPTB (≥800 cases) concurrent with PTB (proportion≥ 30%).

![](pone.0237753.t003){#pone.0237753.t003g}

  id   EPTB                                      N1       N2      Proportion(95%CI) (%)
  ---- ----------------------------------------- -------- ------- -----------------------
  1    pharyngeal / laryngeal tuberculosis       2360     2155    91.31(90.10--92.42)
  2    bronchial tuberculosis                    30367    27185   89.52(89.17--89.86)
  3    tuberculosis of hilar lymph nodes         1001     796     79.52(76.89--81.98)
  4    tuberculosis of mediastinal lymph nodes   3292     2605    79.13(77.70--80.51)
  5    intestinal tuberculosis                   4571     3293    72.04(70.72--73.34)
  6    tuberculous pleurisy                      101808   66492   65.31(65.02--65.60)
  7    tuberculosis of meningitis                14680    9195    62.64(61.85--63.42)
  8    tuberculous polyserositis                 4734     2811    59.38(57.96--60.78)
  9    tuberculous pericarditis                  5766     3357    58.22(56.94--59.50)
  10   tuberculous peritonitis                   9731     5574    57.28(56.29--58.27)
  11   tuberculous empyema                       7203     3728    51.76(50.59--52.92)
  12   chest wall tuberculosis                   4538     2195    48.37(46.91--49.83)
  13   thoracic vertebra tuberculosis            5196     2410    46.38(45.02--47.75)
  14   pleural tuberculoma                       888      407     45.83(42.52--49.18)
  15   tuberculous lymphadenitis of neck         14706    6732    45.78(44.97--46.59)
  16   cutaneous tuberculosis                    849      382     44.99(41.61--48.41)
  17   tuberculosis of axillary lymph nodes      1260     557     44.21(41.44--47.00)
  18   renal tuberculosis                        2772     1193    43.04(41.18--44.91)
  19   pelvic tuberculosis                       1816     777     42.79(40.50--45.10)
  20   knee joint tuberculosis                   1121     454     40.50(37.61--43.44)
  21   hip joint tuberculosis                    878      320     36.45(33.26--39.73)
  22   lumbar vertebra tuberculosis              7019     2515    35.83(34.71--36.97)

N1: the number of EPTB; N2: the number of EPTB concurrent with PTB; Proportion = N2/N1.

The associations between multiple EPTB types and gender-age group {#sec009}
-----------------------------------------------------------------

[Table 4](#pone.0237753.t004){ref-type="table"} illustrated the results of multinomial logistic regression analysis, with exclusively EPTB as the reference category. The results from EPTB concurrent with PTB suggested that females EPTB inpatients were less likely to be at higher risk of concurrent PTB (aOR = 0.819, 95%CI:0.803--0.835) after adjusted by age. As age increasing, the trend risk of concurrent PTB decreased (aOR = 0.994, 95%CI: 0.989--0.999) after adjusted by gender. When set ≥65years as the reference category, the risk of concurrent PTB firstly decreased then increased in EPTB inpatients.

10.1371/journal.pone.0237753.t004

###### The associations between multiple EPTB types and gender-age group[^a^](#t004fn001){ref-type="table-fn"}.

![](pone.0237753.t004){#pone.0237753.t004g}

  Types of EPTB                                                        Variables     No. of concurrent PTB in EPTB (%)   aOR(95%CI)                                    *P*
  -------------------------------------------------------------------- ------------- ----------------------------------- --------------------------------------------- -----
  **EPTB concurrent with PTB**[^b^](#t004fn002){ref-type="table-fn"}   Gender                                                                                          
   Female                                                              48122(37.9)   0.819(0.803--0.835)                 \<0.001                                       
   Male                                                                78883(62.1)   1.0                                                                               
  Age                                                                                                                                                                  
   15--24                                                              27094(21.3)   0.986(0.955--1.017)                 0.374                                         
   25--34                                                              26806(21.1)   0.992(0.961--1.024)                 0.627                                         
   35--44                                                              17193(13.5)   0.876(0.847--0.907)                 \<0.001                                       
   45--54                                                              18154(14.3)   0.886(0.856--0.917)                 \<0.001                                       
   55--64                                                              16835(13.3)   0.921(0.890--0.954)                 \<0.001                                       
   ≥65                                                                 20923(16.5)   1.0                                                                               
   trend test                                                          ---           0.994(0.989--0.999)                 0.030[^c^](#t004fn003){ref-type="table-fn"}   

^a^. The reference category was exclusively EPTB.

^b^. logit(*P*~EPTB\ concurrent\ with\ PTB~/*P*~exclusively\ EPTB~)

^c^. the p value for trend

Discussion {#sec010}
==========

The clinical manifestations of tuberculosis (TB) are divided into pulmonary TB (PTB) and extrapulmonary TB (EPTB). PTB is much more frequent \[[@pone.0237753.ref003]\]. Extrapulmonary tuberculosis (EPTB) refers to the tuberculosis cases of extrapulmonary organs confirmed by bacteriology or clinically diagnosed, such as pleura, lymph nodes, abdomen, urogenital tract, skin, joints and bones, meninges, etc \[[@pone.0237753.ref011]\]. Global EPTB accounts for 13.37--53% of TB \[[@pone.0237753.ref006],[@pone.0237753.ref007],[@pone.0237753.ref015]--[@pone.0237753.ref020]\]. EPTB can coexist with PTB, or occur alone or other EBTB at the same time \[[@pone.0237753.ref009],[@pone.0237753.ref010]\]. In fact, EPTB can present a variety of symptoms, which may be similar to the symptoms of other diseases, which poses a further challenge for diagnosis. In addition, getting the right samples to confirm EPTB is often seen as a challenge \[[@pone.0237753.ref021]\]. The ratio of PTB to EPTB varies with geographical, social, ethnic and economic parameters \[[@pone.0237753.ref022]\]. The composition ratio of EPTB varies greatly in different countries and continents, and the incidence of different types of EPTB varies greatly \[[@pone.0237753.ref009],[@pone.0237753.ref020],[@pone.0237753.ref023],[@pone.0237753.ref024]\]. Our study showed that EPTB inpatients accounted for 48.69% of all TB patients. A prospective multicenter cohort study conducted in Thailand from May 2005 to September 2006 found that of 769 patients, only 461 (60%) were diagnosed with pulmonary TB, 78 (10%) with pulmonary and extrapulmonary tuberculosis, 223 (29%) with extrapulmonary tuberculosis, and extrapulmonary TB at more than one site in seven (1%) patients \[[@pone.0237753.ref025]\]. From January 2007 to December 2017, it was found that 73 patients (44.8%) had PTB, 71 patients (43.6%) had EPTB, 19 patients (11.7%) had PTB and EPTB at the same time in Turkey \[[@pone.0237753.ref026]\]. Of the 44,050 TB cases reported in Spain in 2007--2012, 31,508 (71.53%) were pulmonary tuberculosis and 12,542 (28.47%) were EPTB \[[@pone.0237753.ref027]\]. Almost one-fifth of TB cases in the United States are extrapulmonary tuberculosis. In 253,299 cases, PTB accounted for 73.6% and EPTB 18.7% \[[@pone.0237753.ref006]\]. Information on some 626,093 cases of tuberculosis in Poland from 1974 to 2010 was collected. Out of 62,251 cases, extrapulmonary tuberculosis is the only form of disease (9.9% of all tuberculosis cases) \[[@pone.0237753.ref028]\]. To sum up, extrapulmonary tuberculosis is also a common type.

According to the data of this study, the demographic data of the patient cohort showed that male accounted for 60.17%, female 39.87%. The results are the same as those of Nepal, Turkey, Saudi Arabia and Poland \[[@pone.0237753.ref028]--[@pone.0237753.ref031]\]. A retrospective study of 102 patients with extrapulmonary tuberculosis from 2000 to 2004 was conducted at St. George's University Hospital in Pereira, Colombia. The average age of the patients was 31.6 years, and 62.7% of the patients were males \[[@pone.0237753.ref032]\]. A study from Turkey assessed the percentage and characteristics of cases of extrapulmonary tuberculosis (EPTB) in the industrial city of kokalai, Turkey. 636 cases were diagnosed with EPTB. There were 345 males (54.2%) and 291 females (45.8%). The average age of the patients was 22.5 +/- 17.1 years (1--86 years old); 41.4% of the patients were younger than 15 years old, 30.9% of the patients were between 20--39 years old \[[@pone.0237753.ref024]\]. Gender effect has a strong regulatory effect on the possible confounding factors, which indicates that a possible independent effect needs further study \[[@pone.0237753.ref033]\]. The gender effect in Yone et al., research has made a strong adjustment to the possible confusion, which indicates that a possible independent effect needs further study \[[@pone.0237753.ref033]\]. In general, it has been reported that the gender differences in TB manifestations are not clear \[[@pone.0237753.ref034]\]. Female patients with tuberculosis are more likely to have extrapulmonary manifestations than male patients, which may be related to the role of endocrine factors in the body \[[@pone.0237753.ref035]\]. Sreeramareddy et al., believe that in a high burden country like Nepal, women may be an independent risk factor for EPTB. TB control programs may target young people and women to find EPTB cases \[[@pone.0237753.ref029]\]. Jung et al., also found that women were independent predictors of EBTB in patients with active PTB (ratio 4.35, 95% CI: 1.78--10.63) \[[@pone.0237753.ref036]\]. The continued transmission of tuberculosis among the American born population is one of the causes of the difference in the incidence rate of gender specific diseases in San Francisco. Gender differences in incidence rate of tuberculosis may be due to differences in communication kinetics, rather than deviation from diagnosis or reporting \[[@pone.0237753.ref037]\]. Cellular immunity, hormones, iron metabolism, loss of income and financial barriers, as well as stigma may all be related to sex-specific differences \[[@pone.0237753.ref038]--[@pone.0237753.ref040]\], gender is just one of the factors \[[@pone.0237753.ref033]\]. Women are also the risk factors of high degree of stenosis. Women tend to be more active in EBTB type and multi-level EBTB.

Our study showed that the proportion of 15--24 years and 25--34 years in EPTB inpatients were the most. A Turkish study also showed that most cases of extrapulmonary tuberculosis occur in the 20-40-year age group \[[@pone.0237753.ref031]\]. EPTB was more common at younger ages (\< 25 years) in Nepal \[[@pone.0237753.ref029]\]. The proportion of extrapulmonary tuberculosis in the population aged 0--19 in Poland is higher than that in other age groups \[[@pone.0237753.ref028]\]. Extrapulmonary tuberculosis is more common in Saudi Arabia at a young age (20--29) \[[@pone.0237753.ref019]\]. Sreeramareddy et al., also confirmed that youth may be an independent risk factor for EPTB in high burden countries \[[@pone.0237753.ref029]\]. Why the elderly are not prone to extrapulmonary tuberculosis may be related to the change of immune function in the elderly \[[@pone.0237753.ref041],[@pone.0237753.ref042]\]. In the elderly, about 90% of TB cases are due to reactivation of primary infection. 30% to 50% of individuals may develop disease-free persistent infection. Some old people who have been infected with *Mycobacterium tuberculosis* before may eventually eliminate the living Mycobacterium tuberculosis and return to the tuberculin negative reaction state \[[@pone.0237753.ref043]\]. Generally, there is no consensus on the possible impact of aging on the occurrence of EPTB. It has been suggested that the failure of the immune system with age is related to EPTB, especially miliary and meningeal tuberculosis \[[@pone.0237753.ref044]\]. With the increase of age, the production of many cytokines is a common phenomenon. However, this increase was only evident in the culture stimulated by mitogen. In fact, there is no difference in the spontaneous production of all cytokines between young and old people. This finding not only shows that the cellular mechanisms for the production of these cytokines are best preserved in the cells of the elderly, but also that they can up regulate their production under appropriate stimulation \[[@pone.0237753.ref045]\]. This can happen in inflamed areas of the body, or in other damaged areas, where they can make a significant contribution to the ongoing destructive process \[[@pone.0237753.ref046]\]. One of the physiological characteristics of immune aging may not be accidental, that is, the serum level of most immunoglobulins and subclasses increases \[[@pone.0237753.ref047]\], and the development of monoclonal antibodies is a significant pathological feature of the immune system in the elderly \[[@pone.0237753.ref048]\]. Peto et al., also found that children under 15 years were more likely to have EPTB than those over 15 years \[[@pone.0237753.ref006]\]. A Polish study also showed that the proportion of extrapulmonary tuberculosis in the population aged 0--19 was higher than that in other age groups \[[@pone.0237753.ref028]\]. This may be related to the special physiological characteristics and immune function of children and adolescents. In addition, during bacteremia or blood borne disseminated tuberculosis, which is also the cause of extrapulmonary tuberculosis, children and infants may develop the disease \[[@pone.0237753.ref049],[@pone.0237753.ref050]\].

Our data analysis revealed that there were 364,694 TB lesions in 202,998 EPTB inpatients. On average each EPTB inpatient had 1.80 types of TB lesions. The most common of EPTB (0.4% or about ≥800cases) was tuberculous pleurisy (50.15%, 95%CI:49.93%-50.37%), followed by bronchial tuberculosis (14.96%, 95%CI: 14.80% -15.12%), tuberculous lymphadenitis of the neck (7.24%, 95%CI:7.13%-7.36%), tuberculous meningitis (7.23%, 95%CI:7.12%-7.35%), etc. Other studies have also found that pleural TB is the most common EPTB in sub Saharan Africa(63.2%, 144/228), Poland (36%, 214/599) and Romania (58%, 1606/2781) \[[@pone.0237753.ref021],[@pone.0237753.ref028],[@pone.0237753.ref033]\]. However, other studies found that lymph node tuberculosis is the most common sites of extrapulmonary tuberculosis in the Netherlands (39%, 1963 / 504239%), the United States (40%, 19107 / 47293), the United Kingdom (37%, 10358 / 27762), Saudi Arabia (44.6%, 170 / 381), Turkey (21%, 29 / 141) and Afghanistan (37.3%, 44 / 118) \[[@pone.0237753.ref006],[@pone.0237753.ref007],[@pone.0237753.ref023],[@pone.0237753.ref051]--[@pone.0237753.ref053]\]. Some studies have also shown that the most common type of EPTB is bone and / or joint tuberculosis \[[@pone.0237753.ref054],[@pone.0237753.ref055]\]. Of the 397 study patients in Turkey, 103 (25.9%) had EPTB and 294 (74.1%) had PTB. The two most common types of EPTB were genitourinary tuberculosis (27.2%) and meningeal tuberculosis (19.4%) \[[@pone.0237753.ref030]\]. This kind of different researches and different countries have different forms of common extrapulmonary tuberculosis, which may be related to the following factors: (1) in some countries, the immune function of the population is damaged due to vitamin D deficiency, dietary changes and restrictive social conditions, which leads to endogenous tuberculosis infection easily reactivated from the external parts of the lung, such as lymph nodes, pleura, bone tissue, etc., leading to EPTB in these parts High incidence \[[@pone.0237753.ref056]\]; (2) Genetic factors. NRAMP1 may play a more important role in the localization of Mycobacterium tuberculosis infection than at the beginning of infection, i.e., NRAMP1 could be a major gene governing human susceptibility to extra-pulmonary TB \[[@pone.0237753.ref057]\]. (3) The different genes of Mycobacterium tuberculosis strains may make patients susceptible to tuberculosis in some parts, such as lymph node tuberculosis \[[@pone.0237753.ref055]\]; (4) Bacillus Calmette-Guérin (BCG) immunization has different protective effects on various forms of tuberculosis, but it is not widely used in many countries \[[@pone.0237753.ref020],[@pone.0237753.ref058]\]. Compared with countries without BCG vaccination, nationwide BCG vaccination in China may be related to different infection sites of extrapulmonary tuberculosis \[[@pone.0237753.ref020]\].

It was found that many EPTB inpatients were concurrent with PTB in our study. Laryngeal TB is an important form of tuberculosis. According to its pathogenesis, laryngeal TB can be divided into two types: primary, directly invading the larynx through bacteria; secondary, transmitted through the bronchi of advanced tuberculosis \[[@pone.0237753.ref059]\]. Laryngeal tuberculosis is often associated with pulmonary tuberculosis, but the patient also has tuberculosis of the larynx without a history of tuberculosis \[[@pone.0237753.ref060]\]. The incidence of the pulmonary tuberculosis rate of laryngeal tuberculosis was about 40.6% to 100% \[[@pone.0237753.ref061]--[@pone.0237753.ref063]\]. In our study, there were about 91.31% pharyngeal/laryngeal tuberculosis inpatients concurrent with PTB. In the study of Ling et al., the infection pattern of tuberculosis of larynx in the two groups seems to be different. Before 1990, the chest X-ray of 5 patients with larynx were all positive. After 1998, 8 out of 14 patients (57.1%) had normal chest radiographs and showed no signs of active lung disease \[[@pone.0237753.ref061]\]. Lim et al. found that the pulmonary tuberculosis rate of laryngeal tuberculosis was 80.0% (48/60) \[[@pone.0237753.ref062]\]. Clinical analysis of 22 patients with pathologically confirmed laryngeal tuberculosis was carried out retrospectively. The pulmonary tuberculosis rate of laryngeal tuberculosis was 59.0% (15/22) \[[@pone.0237753.ref063]\]. To sum up, it is assumed that the infection occurred via hematogenous spread from an unidentified source or was primarily laryngeal or spread from pulmonary TB \[[@pone.0237753.ref061],[@pone.0237753.ref063],[@pone.0237753.ref064]\]. Tracheobronchial tuberculosis (TBTB) is a kind of submucous tuberculosis, which mainly occurs in the bronchial mucosa and submucosa. TBTB can be misdiagnosed as bronchitis, bronchial asthma, bronchiectasis or pulmonary carcinoma. TBTB is present in 10%-40% among active tuberculosis patients, and the prevalence of TBTB is increasing in recent years \[[@pone.0237753.ref065]\]. Previous studies showed that the incidence of the pulmonary tuberculosis rate of bronchial tuberculosis was about 48% to 99.4% \[[@pone.0237753.ref066]--[@pone.0237753.ref070]\]. In our study, there were about 89.52% bronchial tuberculosis inpatients concurrent with PTB. Most of previous studies have reported that the prevalence of EBTB inpatients concurrent with PTB were higher, and respectively 99.4% \[[@pone.0237753.ref066]\], 92.1% \[[@pone.0237753.ref067]\], 91.9% \[[@pone.0237753.ref068]\] and 90.9% \[[@pone.0237753.ref069]\]. However, in the study of S Altin et al., only 48% (24/50) bronchial tuberculosis inpatients were concurrent with PTB \[[@pone.0237753.ref070]\]. The reason for different prevalence concurrent with PTB in EBTB is not clear. Some studies found that a number of patients with mediastinal tuberculous lymphadenitis were associated with lung parenchymal infection \[[@pone.0237753.ref071],[@pone.0237753.ref072]\]. In our study, there were about 79.52% tuberculosis of hilar lymph nodes and 79.13% tuberculosis of mediastinal lymph nodes inpatients concurrent with PTB. Wojciech Rzechorzek et al., found that 50.0% (4/8) tuberculosis of hilar lymph nodes inpatients were concurrent with PTB \[[@pone.0237753.ref072]\]. However, another studies found that the incidence of the pulmonary tuberculosis in tuberculous lymphadenitis patients was lower (7.8% to 28.8%) \[[@pone.0237753.ref073]--[@pone.0237753.ref075]\]. Intestinal tuberculosis can result from the hematogenous spread of active tuberculosis or military tuberculosis, the adjacent spread of adjacent organs, the swallowing of active tuberculosis infected sputum or the intake of contaminated milk \[[@pone.0237753.ref076]\]. As a result, pulmonary involvement is not constant, ranging from 9.87% to 68.7% \[[@pone.0237753.ref076]--[@pone.0237753.ref080]\]. Our study showed that the prevalence of intestinal tuberculosis concurrent with PTB was 72.04%, consistent with the result of Kim et al. and Wang et al. \[[@pone.0237753.ref077],[@pone.0237753.ref080]\]. Tuberculous pleurisy or pleural TB is a common manifestation of extrapulmonary TB \[[@pone.0237753.ref081]--[@pone.0237753.ref083]\]. In western countries, pleural tuberculosis makes up less than 1% of exudate and only 3--5% of tuberculosis patients \[[@pone.0237753.ref081],[@pone.0237753.ref082]\]. In contrast, in developing countries like India, pleural TB accounts for 30--80% of all pleural effusion \[[@pone.0237753.ref084]\]. Previous studies reported the prevalence of associated parenchymal lesions ranged from 20 to 95.2% \[[@pone.0237753.ref085]--[@pone.0237753.ref089]\]. Our study found that the prevalence of PTB in the tuberculous pleurisy patients was 65.31%. CT scan can improve the accuracy of diagnosis by recording the related solid lesions and lymphadenopathy. 86% of the patients with tuberculous effusion showed parenchymal lesions on chest CT, and 37% showed radiation-induced tuberculosis \[[@pone.0237753.ref087]\]. Although tuberculous meningitis accounts for only 5--10% of extrapulmonary tuberculosis and 1% of all tuberculosis patients, it kills and maims more patients than any other form of tuberculosis \[[@pone.0237753.ref090]--[@pone.0237753.ref092]\]. In our study, there were about 62.64% tuberculous meningitis inpatients concurrent with PTB. Previous studies have reported that the prevalence of tuberculous meningitis inpatients concurrent with PTB were 29.4% (47/160) \[[@pone.0237753.ref093]\], 45.5% (95/209) \[[@pone.0237753.ref094]\], and 54% \[[@pone.0237753.ref095]\], respectively. A retrospective cohort study found that 58.8% (315/536) were associated with pulmonary tuberculosis, 12.3% were miliary tuberculosis \[[@pone.0237753.ref096]\]. Above studies demonstrated about 10%-100% of EPTB patients have concomitant pulmonary involvement \[[@pone.0237753.ref007],[@pone.0237753.ref015],[@pone.0237753.ref016],[@pone.0237753.ref017],[@pone.0237753.ref020],[@pone.0237753.ref063]\]. Therefore, all suspected cases of EPTB should be assessed for concomitant PTB to determine whether the case is infectious and to assist with diagnosis.

Lastly, multinomial logistic regression analysis in our study showed that female EPTB inpatients were less likely to be at higher risk of concurrent PTB (aOR = 0.819, 95%CI:0.803--0.835) after adjusted by age, and as age increasing, the trend risk of concurrent PTB decreased (aOR = 0.994, 95%CI: 0.989--0.999) after adjusted by gender. The similar results have not been reported in the previous study. The reasons remain to be investigated in the future.

There were several limitations to our study. Firstly, our study results may have been influenced by Berkson's bias. In our study, we selected all patients who were admitted to 21 hospitals with a diagnosis of PTB within a specified time period. There is a high likelihood that these hospitalized patients would have more concurrent tuberculosis in EPTB, relative to patients with EPTB not admitted to hospital. It is therefore likely that our study overestimates the prevalence of concurrent tuberculosis in EPTB patients. Secondly, most of the hospitals included in our study are specialized tuberculosis hospitals. Therefore, these findings may not represent the general EPTB patient population, and may not apply to settings elsewhere in China. Thirdly, many specialized TB hospitals in China do not admit or treat pediatric TB cases. Therefore our results did not study the prevalence of pediatric EPTB. Fourthly, we analyzed the distribution of EPTB by gender and age variables only, and did not collect data on other possible influencing factors, such as income, smoking, alcohol use, recreational drug use, housing arrangements, etc, which may affect the presence of concurrent tuberculosis in EPTB.

Conclusion {#sec011}
==========

Our study demonstrated that the common EPTB were tuberculous pleurisy, bronchial tuberculosis, tuberculous lymphadenitis of the neck, tuberculous meningitis, etc. A majority of patients with pharyngeal/laryngeal tuberculosis, bronchial tuberculosis, tuberculosis of hilar/mediastinal lymph nodes, intestinal tuberculosis, tuberculous pleurisy, tuberculous meningitis, etc. were concurrent with PTB. Female EPTB inpatients were less likely to be at higher risk of concurrent PTB, and as age increasing, the trend risk of concurrent PTB decreased. The clinicians should be alert to the presence of concurrent tuberculosis in EPTB, and all suspected cases of EPTB should be assessed for concomitant PTB to determine whether the case is infectious and to help for early diagnosis and treatment.

Supporting information {#sec012}
======================

###### 

(XLSX)

###### 

Click here for additional data file.

We acknowledge the contributions from Innovation Alliance on Tuberculosis Diagnosis and Treatment (Beijing), and the doctors, laboratory technicians and nursing staff at the 21 hospitals in China involved in this study.

10.1371/journal.pone.0237753.r001

Decision Letter 0

Ehtesham

Hasnain Seyed

Academic Editor

© 2020 Hasnain Seyed Ehtesham

2020

Hasnain Seyed Ehtesham

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

20 Jul 2020

PONE-D-20-17556

The epidemiology of extrapulmonary tuberculosis in China: A large-scale multi-center observational study

PLOS ONE

Dear Dr. Tang,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 03 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <plosone@plos.org>. When you\'re ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled \'Manuscript\'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

We look forward to receiving your revised manuscript.

Kind regards,

Hasnain Seyed Ehtesham

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and

<https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

2\. Thank you for indicating in the Methods section that your ethics board provided approval and that they waived the need for informed patient consent because the study was restrospective and used anonymized data. Please additionally add this information to the Ethics Statement.

3\. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to 'Update my Information' (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: <https://www.youtube.com/watch?v=_xcclfuvtxQ>

4\. Your ethics statement must appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please also ensure that your ethics statement is included in your manuscript, as the ethics section of your online submission will not be published alongside your manuscript.

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The article is good as it presents a huge data collected from 21 hospitals in the country. In the limitations the authors have mentioned that they could not compare the demographic details as income, housing, smoking etc. They also mentioned that they could not procure much data about paediatric tuberculosis.

They have only mentioned number of tuberculosis cases and concurrent pulmonary tuberculosis cases.

However, the following points need to be mentioned:

1\. BCG vaccination policy of China and the vaccination status of the patients.

2\. Immune status of the patients with underlying illnesses.

3\. The number of cases with previous TB infection.

4\. Rate of cure and mortality.

The authors have presented huge amount of data but they haven\'t correlated the data with the above mentioned points and have not related to any demographic details, that is required to be done.

Reviewer \#2: Comments:

As per title and objective, the article written by Kang et al. provides full illustration of epidemiology of EPTB in China. This observational study represented about 202,998 EPTB inpatients with collaboration of 21 hospitals from 15 provinces in China.

However, following suggestive comments will also construct this article stronger and beneficial for the readers:

Abstract:

• Word limits excided as per Journal guidelines. Should be modified while considering word limit.

• Abbreviations of PTB are missing.

Introduction:

• It is advised to add few points with recent references regarding diagnostic modalities and difficulties in diagnosing EP specimens as it is missing form introduction section.

Method:

• Author must specify about bronchial tuberculosis (14.96%), because this may consider under PTB.

Results:

• Risk of EPTB is related to the degree of exposure to the pathogen and host immune factors like HIV, diabetes, malignancy etc. It's my opinion that if author have the related data then this could make article more encouraging to readers.

Discussion:

• Line no. 282: Mycobacterium tuberculosis , write in italic.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0237753.r002

Author response to Decision Letter 0

28 Jul 2020

PONE-D-20-17556

The epidemiology of extrapulmonary tuberculosis in China: A large-scale multi-center observational study

PLOS ONE

Dear Academic Editor Hasnain Seyed Ehtesham,

On behalf of my co-authors, we thank you very much for giving us an opportunity to revise our manuscript. We have tried our best to revise our manuscript according to the comments. At the same time, the revised version has been uploaded.

We are pleased to answer the questions raised by the academic editor and reviewers and the manuscript has also been revised according to the comments.

Journal Requirements:

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and

<https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

Answer: Thank you very much. Our manuscript meets PLOS ONE\'s style requirements.

2\. Thank you for indicating in the Methods section that your ethics board provided approval and that they waived the need for informed patient consent because the study was retrospective and used anonymized data. Please additionally add this information to the Ethics Statement.

Answer: The information has been added to the ethics statement.

3\. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to 'Update my Information' (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: <https://www.youtube.com/watch?v=_xcclfuvtxQ>

Answer: I have an ORCID iD and that it is validated in Editorial Manager.

4\. Your ethics statement must appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please also ensure that your ethics statement is included in your manuscript, as the ethics section of your online submission will not be published alongside your manuscript.

Answer: The ethics statement has been added to the Methods of the manuscript.

Reviewer\'s Responses to Questions
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Answer: Thank you very much for your suggestion. But, we don\'t have data on the degree of exposure to the pathogen and host immune factors in our survey.

Discussion:

• Line no. 282: Mycobacterium tuberculosis, write in italic.
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